Epidermal growth factor receptor family members (EGFR and HEr2) are prognostic markers and potential therapeutic targets in prostate cancer

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [1] Prognostic value of epidermal growth factor receptor (EGFR) family members in breast cancer
    Crnjevic, T. Badovinac
    Jakic-Razumovic, J.
    Vrbanec, D.
    Juretic, A.
    Plestina, S.
    Podolski, P.
    Sarcevic, B.
    Saric, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Epidermal growth factor receptor (EGFR) is a potential therapeutic target in prostate cancer
    Schlomm, T
    Steuber, T
    Chun, KHF
    Watz, J
    Haese, A
    Graefen, M
    Simon, R
    Sauter, G
    Erbersdobler, A
    Huland, H
    JOURNAL OF UROLOGY, 2006, 175 (04): : 258 - 258
  • [3] Epidermal growth factor receptors and penile carcinoma: The role of EGFR and HER2 expression as prognostic and predictive markers
    Silva-Amancio, Alice M. T.
    Cunha, Isabela W.
    Guimaraes, Gustavo C.
    Soares, Fernando A.
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Investigation of the Human Epidermal Growth Factor Receptor Family as Potential Therapeutic Targets for Bladder Cancer
    Vidal, R. Mora
    Packham, G.
    Crabb, S. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S58 - S58
  • [5] The role of the HER2 and HER3 in prostate cancer and their potential as therapeutic targets
    Rao, K.
    Gaughan, L.
    Robson, C.
    McCracken, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S177
  • [6] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Prognostics significance of epidermal growth factor receptor and HER2 overexpression in prostate cancer.
    Schlomm, Thorsten
    Erbersdobler, Andreas
    Luebke, Andreas M.
    Graefen, Markus
    Huland, Hartwig
    Sauter, Guido
    Simon, Ronald
    CANCER RESEARCH, 2006, 66 (08)
  • [8] Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
    Riecke, Kerstin
    Witzel, Isabell
    BREAST CARE, 2020, 15 (06) : 579 - 585
  • [9] Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
    De Vita, F.
    Giuliani, F.
    Silvestris, N.
    Catalano, G.
    Ciardiello, F.
    Orditura, M.
    CANCER TREATMENT REVIEWS, 2010, 36 : S11 - S15
  • [10] Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Siddiqui, Mohammad R.
    Railkar, Reema
    Sanford, Thomas
    Crooks, Daniel R.
    Eckhaus, Michael A.
    Haines, Diana
    Choyke, Peter L.
    Kobayashi, Hisataka
    Agarwal, Piyush K.
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345